drugset
drugset / Trial / NCT02524236

Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.

NCT02524236 ↗

Phase 0 Completed 40 enrolled Beni-Suef University
RandomizedCrossoverQuadruple-blindTreatment

Summary

The primary objective of this study is to compare the efficacy and safety of a single injection of 50 U and 100 U doses of BoNT-A for the treatment of BPH-associated LUTS.

Timeline

Start
2015-08
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 50 iu Other
Comparator Botulinum toxin type A Protein / enzyme biologic 100 iu Other

Indications

benign prostatic hyperplasia